Submission Details
| 510(k) Number | K081251 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 02, 2008 |
| Decision Date | May 13, 2008 |
| Days to Decision | 11 days |
| Submission Type | Special |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K081251 is an FDA 510(k) clearance for the MODIFICATION TO AESKULISA DS DNA G, a Anti-dna Antibody, Antigen And Control (Class II — Special Controls, product code LSW), submitted by Aesku Diagnostics (Wendelsheim, Rheinland, DE). The FDA issued a Cleared decision on May 13, 2008, 11 days after receiving the submission on May 2, 2008. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5100.
| 510(k) Number | K081251 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 02, 2008 |
| Decision Date | May 13, 2008 |
| Days to Decision | 11 days |
| Submission Type | Special |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | LSW — Anti-dna Antibody, Antigen And Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5100 |